Organization
Repros Therapeutics, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Repros Therapeutics, Inc.
... Review: H1 2018 - Covering Merck & Co, Mereo Biopharma Group and Repros Therapeutics - ResearchAndMarkets.com ...
... THE WOODLANDS, Texas, Jan. 26, 2018 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.®, (Nasdaq:RPRX) ("Repros" or the "Company") today announced that, consistent with the ...
... than two months after Allergan struck a deal to acquire the floundering Repros Therapeutics, giving it the rights to a uterine fibroid drug that is ...
... York (January 5, 2018, 4:03 PM EST) -- Reproductive disorder drugmaker Repros Therapeutics Inc. has been hit with a stockholder suit in Delaware federal court ...
... for all current investors, traders, and shareholders of Athersys, Inc. (NASDAQ:ATHX), Repros Therapeutics Inc. (NASDAQ:RPRX), GCP Applied Technologies Inc. (NYSE:GCP), IDACORP, Inc. (NYSE:IDA), Mobile Mini, ...
... free research to the investment community. Today we are offering reports on RPRX, ALDX, NEOT, and BLRX which can be accessed for free by signing ...
... Rigrodsky & Long, P.A.: Do you own shares of Repros Therapeutics Inc. (NASDAQ CM: RPRX )?Did you purchase any of your shares prior to December ...
... & Korsinsky, LLP: To: All Persons or Entities who purchased Repros Therapeutics Inc. ("Repros Therapeutics" or the "Company") (NASDAQ:RPRX) stockprior to December 12, 2017. You ...
... THE WOODLANDS, Texas, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc. (NASDAQ:RPRX) ("Repros" or the "Company") today announced that it has entered ...
... Allergan has struck a deal to acquire the floundering Repros Therapeutics. The bargain-basement takeout gives Allergan the rights to a uterine fibroid ...
Subscribe now for full coverage on Repros Therapeutics, Inc.
Start My Free Trial